Követés
Lajos Gergely, MD, PhD
Lajos Gergely, MD, PhD
University of Debrecen, Inst. of Internal Medicine, Dept. of Hematology
E-mail megerősítve itt: med.unideb.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Cancer‐associated myositis: clinical features and prognostic signs
A Ponyi, T Constantin, M Garami, C András, B Tállai, A Váncsa, L Gergely, ...
Annals of the New York Academy of Sciences 1051 (1), 64-71, 2005
1922005
Malignant lymphoma-associated autoimmune diseases–a descriptive epidemiological study
L Váróczy, L Gergely, M Zeher, G Szegedi, Á Illés
Rheumatology international 22, 233-237, 2002
1712002
Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients
A Váncsa, I Csípő, J Németh, K Dévényi, L Gergely, K Dankó
Rheumatology international 29, 989-994, 2009
1562009
Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis
A Ponyi, G Borgulya, T Constantin, A Váncsa, L Gergely, K Dankó
Rheumatology 44 (1), 83-88, 2005
1492005
Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective …
A Váncsa, L Gergely, A Ponyi, G Lakos, J Németh, P Szodoray, K Dankó
Joint Bone Spine 77 (2), 125-130, 2010
952010
Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis
M Aleksza, A Szegedi, P Antal-Szalmás, B Irinyi, L Gergely, A Ponyi, ...
Annals of the rheumatic diseases 64 (10), 1485-1489, 2005
762005
Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment of B …
A Váncsa, Z Szabó, S Szamosi, N Bodnár, E Végh, L Gergely, G Szűcs, ...
The Journal of rheumatology 40 (5), 565-571, 2013
462013
Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneoplastic pemphigus with cyclosporin A
L Gergely, L Váróczy, G Vadász, É Remenyik, Á Illés
Acta haematologica 109 (4), 202-205, 2003
432003
Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis
É Szekanecz, S Szamosi, L Gergely, P Keszthelyi, Z Szekanecz, G Szűcs
Clinical rheumatology 27, 1163-1166, 2008
302008
Epidural malignant lymphomas of the spine: collected experiences with epidural malignant lymphomas of the spinal canal and their treatment
G Székely, Z Miltényi, G Mezey, Z Simon, J Gyarmati, L Gergely, L Bognár, ...
Spinal Cord 46 (4), 278-281, 2008
302008
A simplified method for Ca2+ flux measurement on isolated human B cells that uses flow cytometry
L Gergely, L Cook, V Agnello
Clinical Diagnostic Laboratory Immunology 4 (1), 70-74, 1997
291997
Intracellular IL‐4/IFN‐gamma producing peripheral T lymphocyte subsets in B cell non‐Hodgkin's lymphoma patients
L Gergely, M Aleksza, L Váróczy, A Ponyi, S Sipka, Á Illés, G Szegedi
European journal of haematology 72 (5), 336-341, 2004
282004
Fc-gamma-receptor IIIa polymorphism and gene expression profile do not predict the prognosis in diffuse large B-cell lymphoma treated with R-CHOP protocol
L Váróczy, E Zilahi, Á Gyetvai, B Kajtár, L Gergely, S Sipka, Á Illés
Pathology & Oncology Research 18, 43-48, 2012
232012
Diagnostics and treatment of pulmonary BALT lymphoma: a report on four cases
L Varoczy, L Gergely, A Illes
Annals of hematology 82, 363-366, 2003
222003
Malignant lymphomas and autoimmunity—a single center experience from Hungary
L Váróczy, E Páyer, Z Kádár, L Gergely, Z Miltényi, F Magyari, P Szodoray, ...
Clinical rheumatology 31, 219-224, 2012
192012
Successful rituximab-CHOP treatment of systemic lupus erythematosus associated with diffuse large B-cell non-Hodgkin lymphoma
Z Simon, T Tarr, Z Ress, L Gergely, E Kiss, A Illes
Rheumatology International 28, 179-183, 2007
142007
Can CD3+/HLA-DR+ activated T cells predict the prognosis of non-Hodgkin's lymphoma patients?
L Váróczy, L Gergely, Z Miltényi, M Aleksza, Á Illés
Immunology letters 97 (1), 155-157, 2005
132005
Interim PET/CT in diffuse large B-cell lymphoma may facilitate identification of good-prognosis patients among IPI-stratified patients
R Nyilas, B Farkas, RR Bicsko, F Magyari, LI Pinczes, A Illes, L Gergely
International Journal of Hematology 110, 331-339, 2019
122019
Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia.
L Váróczy, L Gergely, S Szakáll, A Illés
Haematologia 32 (4), 535-541, 2002
122002
The impact of delayed sample handling and type of anticoagulant on the interpretation of dysplastic signs detected by flow cytometry
B Kárai, Z Miltényi, L Gergely, M Száraz-Széles, J Kappelmayer, ...
Biochemia Medica 28 (2), 296-308, 2018
112018
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20